Advanced solid tumor
Showing 9976 - 10000 of >10,000
Cancer Trial in New Taipei City (solid organ malignancies treatment)
Recruiting
- Cancer
- solid organ malignancies treatment
-
New Taipei City, TaiwanTuCheng Hospital
May 18, 2022
Different Surgical Approaches for Giant Pituitary Adenomas
Recruiting
- Surgery
- Pituitary Adenoma
- Two different approaches
-
Chongqing, Chongqing, China
- +12 more
Oct 13, 2022
Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 Trial in Worldwide (APR-246, Carboplatin and
Completed
- Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
- APR-246
- Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
-
Los Angeles, California
- +54 more
Sep 20, 2022
Neutrophils to Lymphocytes Ratio in Predicting Response to BCG
Completed
- Urinary Bladder Cancer
- +4 more
- Neutrophil to lymphocyte ratio
-
Cairo, EgyptAin Shams university
Jul 15, 2023
Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)
Not yet recruiting
- Metastatic Breast Cancer
- Lobular Breast Carcinoma
- Blood Specimen
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 19, 2023
Breast Tumor, Lymphedema Trial in Edmonton (Standard Care, Exercise and Compression Garment, Exercise and Adjustable Compression
Recruiting
- Breast Neoplasm
- Lymphedema
- Standard Care
- +2 more
-
Edmonton, Alberta, CanadaUniversity of Alberta/ Cross Cancer Institute
Nov 29, 2022
Colon Cancer Trial in Italy (Conventional Right hemicolectomy (Non-CME), Right hemicolectomy with CME+CVL)
Recruiting
- Colon Cancer
- Conventional Right hemicolectomy (Non-CME)
- Right hemicolectomy with CME+CVL
-
Grosseto, Arezzo, Italy
- +13 more
Nov 11, 2022
s From HIV Infection, KSHV Infection, Viral-Related
Recruiting
- HIV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in
Active, not recruiting
- Melanoma
- Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
- Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
-
Toulouse, FranceInstitut Claudius Regaud IUCT-ONCOPOLE
Nov 18, 2022
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Houston
Active, not recruiting
- Malignant Solid Neoplasm
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Covid19, Cancer, Malignancy Trial in Tucson (SARS-COV2 Pfizer Vaccine)
Completed
- Covid19
- +3 more
- SARS-COV2 Pfizer Vaccine
-
Tucson, ArizonaUniversity of Arizona
May 19, 2022
Breast Cancer, Lung Cancer, Solid Tumor Trial in Sacramento (Abraxane, Alimta)
Terminated
- Breast Cancer
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Cancer Center
Jan 5, 2018
Biliary Tract Cancer, Cholangiocarcinoma Trial in Nanjing (SHR-1210+GEMOX)
Completed
- Biliary Tract Cancer
- Cholangiocarcinoma
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Oct 27, 2021
Esophageal Squamous Cell Carcinoma Trial in Worldwide (Durvalumab, Placebo, cisplatin + fluorouracil)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Durvalumab
- +4 more
-
Tucson, Arizona
- +165 more
Jan 18, 2023
Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)
Recruiting
- Pancreatic Cancer Non-resectable
- stereotactic ablative radiotherapy
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Feb 22, 2022
Liver and Spleen Stiffness Measured by TE and 2D-SWE for
Recruiting
- Liver Cirrhosis
- +2 more
- Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital, Sun Yat-sen University
Nov 16, 2023
Peritoneal Carcinomatosis, Gastrointestinal Peritoneal Carcinomatosis Trial in Orange (Biospecimen Collection (Blood,
Not yet recruiting
- Peritoneal Carcinomatosis
- Gastrointestinal Peritoneal Carcinomatosis
- Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples)
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
May 2, 2023